1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
(
- Contribution to journal › Article
- 2018
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
(
- Contribution to journal › Article
-
Mark
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
(
- Contribution to journal › Article
- 2015
-
Mark
The Phosphatases STS1 and STS2 Regulate Hematopoietic Stem and Progenitor Cell Fitness.
(
- Contribution to journal › Article
-
Mark
The role of HOXB2 and HOXB3 in acute myeloid leukemia.
(
- Contribution to journal › Article
- 2013
-
Mark
The presence or absence of IL-3 during long-term culture of Flt3-ITD and c-Kit-D816V expressing Ba/F3 cells influences signaling outcome.
(
- Contribution to journal › Letter
- 2012
-
Mark
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
(
- Contribution to journal › Article
-
Mark
SRC is a signaling mediator in FLT3-ITD-but not in FLT3-TKD-positive AML
(
- Contribution to journal › Article
-
Mark
3,4-Diarylmaleimides-a novel class of kinase inhibitors-effectively induce apoptosis in FLT3-ITD-dependent cells
(
- Contribution to journal › Article
- 2011
-
Mark
Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation
(
- Contribution to journal › Article